TickerGuard
Buy Day today: Neutral (54) Mixed market breadth · no major macro event
PLSE

Pulse Biosciences Inc

Healthcare · Medical Instruments & Supplies

49.80$ -1.5% vs. previous close Closing price · As of: Oct 6, 2026

Statements

Balance Sheet

Pulse Biosciences Inc (PLSE) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 116 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios
Annual Quarterly
Amounts Change % Common size %
Last 12 Full history
Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet PLSE
Line item Q3 16 Q4 16 Q1 17 Q2 17 Q3 17 Q4 17 Q1 18 Q2 18 Q3 18 Q4 18 Q1 19 Q2 19 Q3 19 Q4 19 Q1 20 Q2 20 Q3 20 Q4 20 Q1 21 Q2 21 Q3 21 Q4 21 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
29 26 29 28 54 50 45 40 33 71 63 57 49 42 32 58 50 41 81 80 67 54 40 41 88 78 70 75 66 59 49 40 93 132 133 120 109 96 82 116
19 17 19 16 43 38 34 29 22 60 53 45 36 26 16 39 30 22 62 62 49 37 22 24 71 62 55 60 52 45 36 27 80 119 121 108 97 83 71 106
4.6 2.1 2.8 2.0 32 3.4 11 6.8 6.3 51 8.5 11 9.6 6.9 7.9 38 7.1 12 60 47 42 29 13 15 69 61 54 59 50 44 35 26 79 118 119 106 95 81 68 102
19 16 19 15 42 38 33 27 21 60 53 43 34 25 16 38 30 20 60 47 42 29 13 15 69 61 54 59 50 44 35 26 79 118 119 106 95 81 68 102
– – – – – – – – – – – – – – – – – – -1.0 8.4 0.1 0.1 0.0 0.0 0.0 0.0 0.4 – – – – – – 0.0 – – 0.0 0.3 0.2 0.1
0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 – – – – – – – – – 1.1 2.7 4.3 5.8 7.5 7.9 0.8 0.0 – – – – – – – 0.0 0.0 0.1 0.1 0.1 0.2 0.2
0.3 0.3 0.3 2.7 2.6 2.6 2.5 2.4 2.3 2.2 2.1 3.2 3.6 7.7 7.7 12 2.6 2.5 2.4 12 2.4 11 11 11 11 – 1.9 1.8 – – – – – – – – – – – –
2.8 2.8 2.8 2.8 2.8 2.8 2.8 2.8 2.8 2.8 2.8 2.8 2.8 2.8 2.8 2.8 2.8 2.8 2.8 2.8 2.8 2.8 2.8 2.8 2.8 2.8 2.8 2.8 2.8 2.8 2.8 2.8 2.8 2.8 2.8 2.8 2.8 2.8 2.8 2.8
6.7 6.5 6.4 6.2 6.0 5.9 5.7 5.5 5.4 5.2 5.0 4.9 4.7 4.5 4.4 4.2 4.0 3.9 3.7 3.5 3.4 3.2 3.1 2.9 2.7 2.6 2.4 2.2 2.1 1.9 1.7 1.6 1.4 1.2 1.1 0.9 0.7 0.6 0.4 0.2
1.0 1.0 1.2 3.8 4.2 3.8 3.7 4.5 4.7 4.3 4.3 7.2 7.7 11 10 16 17 18 60 20 20 19 19 17 81 80 81 14 14 15 13 13 14 18 15 16 16 15 15 16
1.0 1.0 1.2 2.0 2.5 2.2 2.2 3.1 3.3 3.1 3.1 3.4 4.0 4.5 3.4 4.9 6.0 7.6 8.5 9.8 9.5 8.5 8.9 7.6 7.0 6.0 7.0 5.6 5.4 6.7 5.1 6.0 6.7 10 7.8 9.0 9.7 7.9 9.8 11
– – – – – – – – – – 0.4 0.2 0.2 – 0.1 0.3 0.5 0.5 0.7 2.4 1.8 1.2 0.8 0.8 1.0 1.8 1.7 1.0 1.0 1.1 1.1 1.1 1.2 1.4 1.4 1.5 1.5 1.6 1.6 1.7
0.4 0.3 0.8 0.9 0.9 0.8 0.9 1.5 1.3 1.3 1.2 1.6 1.8 2.0 1.2 1.5 1.4 1.7 2.2 2.8 2.7 2.9 3.5 1.9 2.0 1.6 2.2 1.8 1.4 1.8 1.7 1.6 1.7 1.7 2.4 2.7 3.0 2.8 2.8 2.8
0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 – 1.2 – – – – – – – 41 – – – – – 65 65 65 – – – – – – – – – – – – –
28 25 27 24 50 46 41 35 28 66 59 50 41 31 22 42 33 23 20 60 47 36 21 23 6.2 -2.2 -11 61 52 44 36 27 79 115 118 104 93 81 66 100
-9.8 -13 -16 -22 -29 -38 -47 -56 -67 -76 -86 -97 -109 -123 -135 -146 -159 -173 -191 -207 -221 -236 -253 -267 -286 -295 -305 -314 -325 -337 -347 -358 -371 -391 -407 -426 -446 -463 -482 -507
13 13 14 14 14 17 17 17 17 18 21 21 21 21 21 22 25 25 26 26 30 30 30 31 37 37 37 45 55 55 55 57 61 58 67 67 67 67 68 69

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: October 6, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?